1974 - 1975年蒙古人民共和国流行性脑脊髓膜炎疫情期间的免疫接种
Immunization during a cerebrospinal meningitis epidemic in the Mongolian People's Republic, 1974-75.
作者信息
Jamba G, Bytchenko B, Causse G, Cvjetanović B, Ocirvan G, Tsend N, Kupul J, Tseren S, Batsuri A, Hisigdorj A, Burian V
出版信息
Bull World Health Organ. 1979;57(6):943-6.
Abstract
An epidemic of cerebrospinal meningitis (CSM) in the Mongolian People's Republic, starting in 1969, reached its peak in 1974. In that year and in early 1975, 65 000 children in the 0-8-years age group in the main towns and in the provinces were immunized with meningococcal vaccine of serogroup A. The morbidity rates due to CSM were 12 times higher in the non-immunized than in the immunized children. This result demonstrates the value of an immunization programme to control epidemics of CSM.
摘要
蒙古人民共和国自1969年开始的脑脊髓膜炎（CSM）疫情，在1974年达到高峰。在该年及1975年初，主要城镇和省份中0至8岁年龄组的65000名儿童接种了A群脑膜炎球菌疫苗。未接种疫苗的儿童中CSM发病率比接种疫苗的儿童高12倍。这一结果证明了免疫规划对于控制CSM疫情的价值。
相似文献
1
Immunization during a cerebrospinal meningitis epidemic in the Mongolian People's Republic, 1974-75.1974 - 1975年蒙古人民共和国流行性脑脊髓膜炎疫情期间的免疫接种
Bull World Health Organ. 1979;57(6):943-6.
2
Meningococcal meningitis in CSR: a preepidemic situation?社区获得性肺炎中的脑膜炎球菌性脑膜炎：一种流行前的情况？
Zentralbl Bakteriol Mikrobiol Hyg A. 1984 May;257(1):195-203.
3
4
[Epidemic of Neisseria meningitidis cerebrospinal meningitis in the Ruhengeri health district (Rwanda)].[卢旺达鲁亨盖里卫生区脑膜炎奈瑟菌性脑脊髓膜炎疫情]
Med Trop (Mars). 1983 Mar-Apr;43(2):155-61.
5
6
[Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method].[采用分区免疫法对A群流行性脑脊髓膜炎多糖疫苗进行9年流行病学效果观察]
Zhonghua Liu Xing Bing Xue Za Zhi. 1991 Apr;12(2):69-71.
7
Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.撒哈拉以南非洲地区的脑膜炎球菌性脑膜炎：使用现有多糖疫苗进行大规模和常规疫苗接种的理由。
Bull World Health Organ. 2003;81(10):745-50; discussion 751-5. Epub 2003 Nov 25.
8
[Epidemiological and control aspects of meningococcal meningitis epidemics in Africa].[非洲脑膜炎球菌性脑膜炎疫情的流行病学及防控方面]
Sante. 1994 May-Jun;4(3):231-6.
9
[Changes in epidemic features of epidemic cerebrospinal meningitis after vaccination with purified meningococcal polysaccharide vaccine group A in Zhengzhou].[郑州市接种A群脑膜炎球菌多糖疫苗后流行性脑脊髓膜炎流行特征变化]
Zhonghua Yu Fang Yi Xue Za Zhi. 1993 May;27(3):160-1.
10
Epidemiology of meningococcal meningitis in Romania 1971-1991.1971 - 1991年罗马尼亚脑膜炎球菌性脑膜炎的流行病学
Roum Arch Microbiol Immunol. 1993 Jan-Mar;52(1):57-65.
引用本文的文献
1
Standing on the shoulders of giants: two centuries of struggle against meningococcal disease.站在巨人的肩膀上：两个世纪以来对抗脑膜炎球菌病的斗争。
Lancet Infect Dis. 2019 Aug;19(8):e284-e294. doi: 10.1016/S1473-3099(19)30040-4. Epub 2019 Apr 30.
2
Meningococcal disease in Asia: an under-recognized public health burden.亚洲的脑膜炎球菌病：一个被低估的公共卫生负担。
Epidemiol Infect. 2011 Jul;139(7):967-85. doi: 10.1017/S0950268811000574. Epub 2011 Apr 15.
3
Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.用于预防A群脑膜炎球菌性脑膜炎的多糖疫苗。
Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD001093. doi: 10.1002/14651858.CD001093.pub2.
4
Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.在沙特阿拉伯，重复接种A/C群脑膜炎球菌多糖疫苗后，对C群而非A群存在免疫低反应性。
Clin Diagn Lab Immunol. 2004 Jan;11(1):83-8. doi: 10.1128/cdli.11.1.83-88.2004.
5
Meningococcal vaccines. Current status and future possibilities.脑膜炎球菌疫苗。现状与未来可能性。
Drugs. 1998 Mar;55(3):347-66. doi: 10.2165/00003495-199855030-00003.
6
Meningococcal disease in Scandinavia.斯堪的纳维亚半岛的脑膜炎球菌病。
Br Med J (Clin Res Ed). 1982 May 29;284(6329):1618-21. doi: 10.1136/bmj.284.6329.1618.
7
Epidemiology of meningococcal meningitis in Sahel and Mongolia.萨赫勒地区和蒙古的脑膜炎球菌性脑膜炎流行病学
Infection. 1984;12 Suppl 1:S35-43. doi: 10.1007/BF01641740.
8
Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.一种新型四价脑膜炎球菌多糖疫苗的免疫原性和副作用
Bull World Health Organ. 1983;61(2):317-23.
9
Functional epidemiology of bacterial meningitis.细菌性脑膜炎的功能流行病学
Infection. 1984;12 Suppl 1:S29-34. doi: 10.1007/BF01641738.
本文引用的文献
1
A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.在亚历山大港进行的A群脑膜炎球菌多糖疫苗的第二项对照现场试验。
Bull World Health Organ. 1977;55(6):645-51.
Zotero 插件